Publications

• One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.

  (Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, Elhaddad A, Frutos C, Galeano S, Hamad N, Hamidieh AA, Hashmi S, Ho A, Horowitz MM, Iida M, Jaimovich G, Karduss A, Kodera Y, Kröger N, Péffault de Latour R, Lee JW, Martínez-Rolón J, Pasquini MC, Passweg J, Paulson K, Seber A, Snowden JA, Srivastava A, Szer J, Weisdorf D, Worel N, Koh MBC, Aljurf M, Greinix H, Atsuta Y, Saber W.) Haematologica. 2022 May 01;107(5):1045-1053 PMID: 34382386 PMCID: PMC9052915 SCOPUS ID: 2-s2.0-85129777388 08/13/2021

• Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.

  (Shadman M, Pasquini M, Ahn KW, Chen Y, Turtle CJ, Hematti P, Cohen JB, Khimani F, Ganguly S, Merryman RW, Yared JA, Locke FL, Ahmed N, Munshi PN, Beitinjaneh A, Reagan PM, Herrera AF, Sauter CS, Kharfan-Dabaja MA, Hamadani M.) Blood. 2022 03 03;139(9):1330-1339 PMID: 34570879 PMCID: PMC8900276 SCOPUS ID: 2-s2.0-85125439632 09/28/2021

• Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).

  (Dispenzieri A, Krishnan A, Arendt B, Blackwell B, Wallace PK, Dasari S, Vogl DT, Efebera Y, Fei M, Geller N, Giralt S, Hahn T, Howard A, Kohlhagen M, Landau H, Hari P, Pasquini MC, Qazilbash MH, McCarthy P, Shah N, Vesole DH, Stadtmauer E, Murray D.) Blood Cancer J. 2022 02 10;12(2):27 PMID: 35145071 PMCID: PMC8831597 SCOPUS ID: 2-s2.0-85124447448 02/12/2022

• Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.

  (Luznik L, Pasquini MC, Logan B, Soiffer RJ, Wu J, Devine SM, Geller N, Giralt S, Heslop HE, Horowitz MM, Jones RJ, Litzow MR, Mendizabal A, Muffly L, Nemecek ER, O'Donnell L, O'Reilly RJ, Palencia R, Schetelig J, Shune L, Solomon SR, Vasu S, Ho VT, Perales MA.) J Clin Oncol. 2022 02 01;40(4):356-368 PMID: 34855460 PMCID: PMC8797487 SCOPUS ID: 2-s2.0-85123901255 12/03/2021

• Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis.

  (Hamadani M, Gopal AK, Pasquini M, Kim S, Qiu X, Ahmed S, Lazaryan A, Bhatt VR, Daly A, Lulla P, Ciurea S, Gauthier J, Agrawal V, Grover NS, Lekakis L, Modi D, Dahi PB, Herr MM, Johnson PC, Hashmi H, Hematti P, Locke FL.) Blood Adv. 2022 Jan 25;6(2):486-494 PMID: 34673903 PMCID: PMC8791562 SCOPUS ID: 2-s2.0-85123544420 10/22/2021

• Decrease post-transplant relapse using donor-derived expanded NK-cells

  (Ciurea SO, Kongtim P, Soebbing D, Trikha P, Behbehani G, Rondon G, Olson A, Bashir Q, Gulbis AM, Indreshpal K, Rezvani K, Shpall EJ, Bassett R, Cao K, Martin AS, Devine S, Horowitz M, Pasquini M, Lee DA, Champlin RE.) Leukemia. January 2022;36(1):155-164 SCOPUS ID: 2-s2.0-85111619774 01/01/2022

• Decrease post-transplant relapse using donor-derived expanded NK-cells.

  (Ciurea SO, Kongtim P, Soebbing D, Trikha P, Behbehani G, Rondon G, Olson A, Bashir Q, Gulbis AM, Indreshpal K, Rezvani K, Shpall EJ, Bassett R, Cao K, Martin AS, Devine S, Horowitz M, Pasquini M, Lee DA, Champlin RE.) Leukemia. 2022 01;36(1):155-164 PMID: 34312462 PMCID: PMC8727305 SCOPUS ID: 2-s2.0-85111619774 07/28/2021

• Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients.

  (Maiolino A, Costa LJ, Pasquini M, Crusoe EQ, Vigorito AC, Salvino MA, Seguro FS, Filho JS, Hungria VTM.) Hematol Transfus Cell Ther. 2021 Nov;43 Suppl 2:S30-S34 PMID: 34794794 PMCID: PMC8606706 11/20/2021

• Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year.

  (Heslop HE, Stadtmauer EA, Levine JE, Ballen KK, Chen YB, DeZern AE, Eapen M, Hamadani M, Hamilton BK, Hari P, Jones RJ, Logan BR, Kean LS, Leifer ES, Locke FL, Maziarz RT, Nemecek ER, Pasquini M, Phelan R, Riches ML, Shaw BE, Walters MC, Foley A, Devine SM, Horowitz MM.) Transplant Cell Ther. 2021 11;27(11):885-907 PMID: 34461278 PMCID: PMC8556300 SCOPUS ID: 2-s2.0-85116810681 08/31/2021

• Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation.

  (Hahn T, Wang J, Preus LM, Karaesmen E, Rizvi A, Clay-Gilmour AI, Zhu Q, Wang Y, Yan L, Liu S, Stram DO, Pooler L, Sheng X, Haiman CA, Berg DVD, Webb A, Brock G, Spellman SR, Onel K, McCarthy PL, Pasquini MC, Sucheston-Campbell LE.) EClinicalMedicine. 2021 Oct;40:101093 PMID: 34746714 PMCID: PMC8548922 11/09/2021

• Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia.

  (Wang Y, Zhou W, McReynolds LJ, Katki HA, Griffiths EA, Thota S, Machiela MJ, Yeager M, McCarthy P, Pasquini M, Wang J, Karaesmen E, Rizvi A, Preus L, Tang H, Wang Y, Pooler L, Sheng X, Haiman CA, Van Den Berg D, Spellman SR, Wang T, Kuxhausen M, Chanock SJ, Lee SJ, Hahn TE, Sucheston-Campbell LE, Gadalla SM.) Sci Rep. 2021 07 22;11(1):15004 PMID: 34294836 PMCID: PMC8298542 SCOPUS ID: 2-s2.0-85111080464 07/24/2021

• Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients

  (Maiolino A, Costa LJ, Pasquini M, Crusoe EdQ, Vigorito AC, Salvino MA, Seguro FS, Filho JS, Hungria VTdM.) Hematology, Transfusion and Cell Therapy. November 2021;43:S30-S34 SCOPUS ID: 2-s2.0-85119602974 11/01/2021